Top Markets
Coin of the day
BioSenic S.A. BioSenic S.A.

BioSenic S.A.

BIOS
Rangering i aksjer #37641
BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium,... BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium, is dedicated to progressing clinical therapeutic solutions. The firm utilizes two primary technology platforms: an innovative allogeneic cell and gene therapy system featuring distinct bone marrow-derived mesenchymal stromal cells designed for convenient on-site hospital storage; and an Arsenic Trioxide platform. The latter is deployed in immuno-oncology to target illnesses such as graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's leading experimental drug, ALLOB, is currently undergoing a Phase IIb clinical trial for patients with complicated tibial fractures.
Aksjekurs
$0.00237231
Sist synkronisert: 2026-06-22
Markedsverdi
$1.55M
Endring (1 dag)
0.00%
Endring (1 år)
-18.94%
Land
BE
Handel BioSenic S.A. (BIOS)

Kategori

P/S-forhold for BioSenic S.A. (BIOS)
P/S-forhold per 2026 TTM: 0
Ifølge BioSenic S.A. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for BioSenic S.A. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
9.88 -
US
10.13 -
NL
- -
CH
- -
KR
4.74 -
BE